CREB1 and rheumatoid arthritis: Recent investigations by Liu [56] unveiled that isorhamnetin can additionally suppress the overexpression of MMP2 and MMP9 by downregulating the phosphorylation level of key proteins in the SRC/ERK/CREB pathway, thus manifesting anti-RA properties.